These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25736705)

  • 21. Malignant hyperthermia with excellent response to small dose of dantrolene.
    Chang KY; Ting CK; Chan KH; Tsai SK
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malignant hyperthermia in swine during isoflurane anesthesia].
    Sümpelmann R; Bötel C; Zimmermann M; Krohn S; Strauss JM; Paul T
    Dtsch Tierarztl Wochenschr; 1994 May; 101(5):207-8. PubMed ID: 8013300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant hyperthermia].
    Zimprich F; Kress HG; Zeitlhofer J
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):556-62. PubMed ID: 14531168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognizing and treating malignant hyperthermia.
    Corvetto MA; Taekman JM
    Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant hyperthermia: responses of skeletal muscles to general anesthetics.
    Gallant EM; Ahern CP
    Mayo Clin Proc; 1983 Nov; 58(11):758-63. PubMed ID: 6355673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
    Dexter F; Epstein RH; Wachtel RE; Rosenberg H
    Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant hyperthermia.
    Ali SZ; Taguchi A; Rosenberg H
    Best Pract Res Clin Anaesthesiol; 2003 Dec; 17(4):519-33. PubMed ID: 14661655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesiol Reanim; 1991; 16(3):202-7. PubMed ID: 1888426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
    Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dantrolene in human malignant hyperthermia.
    Kolb ME; Horne ML; Martz R
    Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dantrolene for malignant hyperthermia during anesthesia.
    Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant hyperthermia: a potentially fatal complication of anesthesia.
    Stolworthy C; Haas RE
    Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
    Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G
    Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human malignant hyperthermia associated with desflurane anesthesia.
    Allen GC; Brubaker CL
    Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529
    [No Abstract]   [Full Text] [Related]  

  • 36. Delayed onset of malignant hyperthermia in desflurane anesthesia.
    Hoenemann CW; Halene-Holtgraeve TB; Booke M; Hinder F; Daudel F; Reich A; Van Aken H
    Anesth Analg; 2003 Jan; 96(1):165-7, table of contents. PubMed ID: 12505945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperthermia.
    Denborough M
    Lancet; 1998 Oct; 352(9134):1131-6. PubMed ID: 9798607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A survey for prevention and treatment of malignant hyperthermia in Taiwan.
    Yip WH; Mingi CL; Ooi SJ; Chen SC; Chiang YY
    Acta Anaesthesiol Taiwan; 2004 Sep; 42(3):147-51. PubMed ID: 15551892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of malignant hyperthermia without hyperthermia].
    Muiños PA; Ortells MA; Sánchez G; Carrasco MS
    Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530
    [No Abstract]   [Full Text] [Related]  

  • 40. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
    Patil PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.